Shenzhen Kexing Pharmaceutical Co., Ltd.
Shenzhen Kexing Pharmaceutical Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD) | Neovascular Age-Related Macular Degeneration (nAMD) | Not yet recruiting | Phase 1 | 2026-02-12 | NCT07406438 | |
| To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants | Cancer Cachexia; Cancer Cachexia (CC); Cancer Cachexia Syndrome | Recruiting | Phase 1 | 2025-11-19 | NCT07237464 | |
| Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency | Bone Diseases, Developmental, Bone Diseases, Endocrine, Dwarfism, bone disorder, brain disorder, central nervous system disorder, endocrine system disorder, hypopituitarism, hypothalamic disorder, musculoskeletal system disorder, nervous system disorder, pituitary dwarfism, pituitary gland disorder | Not yet recruiting | Phase 2 / Phase 3 | 2025-08-22 | NCT07126288 |